EIGER BIOPHARMACEUTICALS INC's ticker is EIGR and the CUSIP is 28249U105. A total of 51 filers reported holding EIGER BIOPHARMACEUTICALS INC in Q3 2023. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $122 | -56.7% | 400 | 0.0% | 0.00% | – |
| Q2 2023 | $282 | -21.4% | 400 | 0.0% | 0.00% | – |
| Q1 2023 | $359 | -23.9% | 400 | 0.0% | 0.00% | – |
| Q4 2022 | $472 | -84.3% | 400 | 0.0% | 0.00% | – |
| Q3 2022 | $3,000 | 0.0% | 400 | 0.0% | 0.00% | – |
| Q2 2022 | $3,000 | 0.0% | 400 | 0.0% | 0.00% | – |
| Q1 2022 | $3,000 | +50.0% | 400 | 0.0% | 0.00% | – |
| Q4 2021 | $2,000 | -33.3% | 400 | 0.0% | 0.00% | – |
| Q3 2021 | $3,000 | 0.0% | 400 | 0.0% | 0.00% | – |
| Q2 2021 | $3,000 | -99.9% | 400 | 0.0% | 0.00% | -100.0% |
| Q1 2021 | $3,540,000 | +70700.0% | 400 | 0.0% | 0.00% | 0.0% |
| Q4 2020 | $5,000 | +66.7% | 400 | 0.0% | 0.00% | 0.0% |
| Q3 2020 | $3,000 | -25.0% | 400 | 0.0% | 0.00% | 0.0% |
| Q2 2020 | $4,000 | +33.3% | 400 | 0.0% | 0.00% | 0.0% |
| Q1 2020 | $3,000 | -75.0% | 400 | -50.0% | 0.00% | -50.0% |
| Q4 2019 | $12,000 | +140.0% | 800 | +68.1% | 0.00% | 0.0% |
| Q3 2019 | $5,000 | – | 476 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Simplify Asset Management Inc. | 2,700,000 | $823,500 | 0.09% |
| 683 Capital Management, LLC | 2,650,000 | $808,250 | 0.06% |
| GSA CAPITAL PARTNERS LLP | 355,867 | $109 | 0.01% |
| RBF Capital, LLC | 391,265 | $119,336 | 0.01% |
| UBS OCONNOR LLC | 393,975 | $120,162 | 0.00% |
| XTX Topco Ltd | 15,597 | $4,757 | 0.00% |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | 106,700 | $32,544 | 0.00% |
| AMERIPRISE FINANCIAL INC | 8,592,471 | $2,620,704 | 0.00% |
| DRW Securities, LLC | 120,365 | $37 | 0.00% |
| DFPG INVESTMENTS, LLC | 32,430 | $10,896 | 0.00% |